Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 61 referenced papers

Top Authors

Robert A. Weinberg
Ludwig Cancer Research
Arthur W. Lambert
Whitehead Institute for Biomedical Research
Cédric Blanpain
Université Libre de Bruxelles
Shigeo Tamiya
The Ohio State University
Henry J. Kaplan
Saint Louis University
Caroline E. Gargett
Hudson Institute of Medical Research
Carlos Simón
INCLIVA Health Research Institute
Salvatore Giovanni Vitale
University of Catania
Eva Dreisler
University of Copenhagen
Jens Jørgen Kjer
University of Copenhagen

Top Institutions

Ranked by publications Top 10 institutions
02

Nanjing Drum Tower Hospital

Nanjing, China

34 papers
03

Capital Medical University

Beijing, China

77 papers
04
05
07

Ludwig Cancer Research

Brussels, Belgium

18 papers
Contributors Robert A. Weinberg
08

Sir Run Run Shaw Hospital

Hangzhou, China

19 papers

References

References (61)
  1. 1

    MicroRNA-29b Inhibits Endometrial Fibrosis by Regulating the Sp1-TGF-β1/Smad-CTGF Axis in a Rat Model.

    Li J, Du S, Sheng X, et al.

    Reproductive sciences (Thousand Oaks, Calif.) 2016; (23(3)):386-94 doi:10.1177/1933719115602768.

    PMID: 26392347
  2. 2

    Results of centralized Asherman surgery, 2003-2013.

    Hanstede MM, van der Meij E, Goedemans L, Emanuel MH

    Fertility and sterility 2015; (104(6)):1561-8.e1.

    PMID: 26428306
  3. 3

    Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy.

    Tamiya S, Kaplan HJ

    Experimental eye research 2016; (142()):26-31.

    PMID: 26675400
  4. 4

    Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience.

    Bhandari S, Bhave P, Ganguly I, et al.

    Journal of reproduction & infertility 2015; (16(4)):229-35.

    PMID: 27110522
  5. 5

    Hysteroscopic adhesiolysis: efficacy and safety.

    Sanad AS, Aboulfotouh ME

    Archives of gynecology and obstetrics 2016; (294(2)):411-6 doi:10.1007/s00404-016-4107-9.

    PMID: 27129970
  6. 6

    Intrauterine Adhesions Following Miscarriage: Look and Learn.

    Gilman AR, Dewar KM, Rhone SA, Fluker MR

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2016; (38(5)):453-7.

    PMID: 27261221
  7. 7

    A prospective, randomized, controlled trial comparing two doses of oestrogen therapy after hysteroscopic adhesiolysis to prevent intrauterine adhesion recurrence.

    Guo J, Li TC, Liu Y, et al.

    Reproductive biomedicine online 2017; (35(5)):555-561 doi:10.1016/j.rbmo.2017.07.011.

    PMID: 28784336
  8. 8

    N-cadherin identifies human endometrial epithelial progenitor cells by in vitro stem cell assays.

    Nguyen HPT, Xiao L, Deane JA, et al.

    Human reproduction (Oxford, England) 2017; (32(11)):2254-2268 doi:10.1093/humrep/dex289.

    PMID: 29040564
  9. 9

    The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study.

    Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D

    Medicine 2018; (97(32)):e11797 doi:10.1097/MD.0000000000011797.

    PMID: 30095642
  10. 10

    Uterine stem cells: from basic research to advanced cell therapies.

    Santamaria X, Mas A, Cervelló I, et al.

    Human reproduction update 2018; (24(6)):673-693 doi:10.1093/humupd/dmy028.

    PMID: 30239705
  11. 11

    Asherman's syndrome: current perspectives on diagnosis and management.

    Dreisler E, Kjer JJ

    International journal of women's health 2019; (11()):191-198 doi:10.2147/IJWH.S165474.

    PMID: 30936754
  12. 12

    Estrogen therapy before hysteroscopic adhesiolysis improves the fertility outcome in patients with intrauterine adhesions.

    Zhang L, Wang M, Zhang Q, et al.

    Archives of gynecology and obstetrics 2019; (300(4)):933-939 doi:10.1007/s00404-019-05249-y.

    PMID: 31350664
  13. 13

    Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions.

    Sebbag L, Even M, Fay S, et al.

    Frontiers in surgery 2019; (6()):50 doi:10.3389/fsurg.2019.00050.

    PMID: 31475154
  14. 14

    CSF1-associated decrease in endometrial macrophages may contribute to Asherman's syndrome.

    Liu D, Wang J, Zhao G, et al.

    American journal of reproductive immunology (New York, N.Y. : 1989) 2020; (83(1)):e13191 doi:10.1111/aji.13191.

    PMID: 31536655
  15. 15

    Efficacy of silicone sheet as a personalized barrier for preventing adhesion reformation after hysteroscopic adhesiolysis of intrauterine adhesions.

    Azumaguchi A, Henmi H, Saito T

    Reproductive medicine and biology 2019; (18(4)):378-383 doi:10.1002/rmb2.12294.

    PMID: 31607798
  16. 16

    Meta-analysis of the use of hyaluronic acid gel to prevent intrauterine adhesions after miscarriage.

    Fei Z, Xin X, Fei H, Yuechong C

    European journal of obstetrics, gynecology, and reproductive biology 2020; (244()):1-4 doi:10.1016/j.ejogrb.2019.10.018.

    PMID: 31731019
  17. 17

    Endothelium-mediated contributions to fibrosis.

    Sun X, Nkennor B, Mastikhina O, et al.

    Seminars in cell & developmental biology 2020; (101()):78-86 doi:10.1016/j.semcdb.2019.10.015.

    PMID: 31791693
  18. 18

    Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?

    Kelley AS, Giuliani E, Schon SB

    Clinical obstetrics and gynecology 2020; (63(2)):320-326 doi:10.1097/GRF.0000000000000510.

    PMID: 31815774
  19. 19

    Expression of ALDH1A Isozymes in Human Endometrium with and without Endometriosis and in Ovarian Endometrioma.

    Ma S, Hirata T, Arakawa T, et al.

    Reproductive sciences (Thousand Oaks, Calif.) 2020; (27(1)):443-452 doi:10.1007/s43032-019-00041-4.

    PMID: 32046407
  20. 20

    Logistic regression analyses of factors affecting fertility of intrauterine adhesions patients.

    Zhao X, Liu Y, Zhang A, et al.

    Annals of translational medicine 2020; (8(4)):49 doi:10.21037/atm.2019.11.115.

    PMID: 32175343
  21. 21

    Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations.

    Zheng F, Xin X, He F, et al.

    Experimental and therapeutic medicine 2020; (19(4)):2672-2678 doi:10.3892/etm.2020.8483.

    PMID: 32256748
  22. 22

    Intrauterine adhesions: What is the pregnancy rate after hysteroscopic management?

    Capmas P, Mihalache A, Duminil L, et al.

    Journal of gynecology obstetrics and human reproduction 2020; (49(7)):101797 doi:10.1016/j.jogoh.2020.101797.

    PMID: 32413519
  23. 23

    Adipose derived mesenchymal stem cell treatment in experimental asherman syndrome induced rats.

    Çil N, Yaka M, Ünal MS, et al.

    Molecular biology reports 2020; (47(6)):4541-4552 doi:10.1007/s11033-020-05505-4.

    PMID: 32444974
  24. 24

    Asherman syndrome: Audit of a single-operator cohort of 423 cases.

    Vancaillie T, Chan K, Liu J, et al.

    The Australian & New Zealand journal of obstetrics & gynaecology 2020; (60(4)):574-578 doi:10.1111/ajo.13182.

    PMID: 32458458
  25. 25

    The incidence of placenta related disease after the hysteroscopic adhesiolysis in patients with intrauterine adhesions.

    Zhang LP, Wang M, Shang X, et al.

    Taiwanese journal of obstetrics & gynecology 2020; (59(4)):575-579 doi:10.1016/j.tjog.2020.05.018.

    PMID: 32653132
  26. 26

    Mini-Review of the New Therapeutic Possibilities in Asherman Syndrome-Where Are We after One Hundred and Twenty-Six Years?

    Doroftei B, Dabuleanu AM, Ilie OD, et al.

    Diagnostics (Basel, Switzerland) 2020; (10(9)) doi:10.3390/diagnostics10090706.

    PMID: 32957624
  27. 27

    Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.

    Wang J, Movilla P, Morales B, et al.

    Journal of minimally invasive gynecology 2021; (28(7)):1357-1366.e2 doi:10.1016/j.jmig.2020.10.004.

    PMID: 33065259
  28. 28

    Identifying the risk factors and incidence of Asherman Syndrome in women with post-abortion uterine curettage.

    Sevinç F, Oskovi-Kaplan ZA, Çelen Ş, et al.

    The journal of obstetrics and gynaecology research 2021; (47(4)):1549-1555 doi:10.1111/jog.14667.

    PMID: 33462894
  29. 29

    Linking EMT programmes to normal and neoplastic epithelial stem cells.

    Lambert AW, Weinberg RA

    Nature reviews. Cancer 2021; (21(5)):325-338 doi:10.1038/s41568-021-00332-6.

    PMID: 33547455
  30. 30

    Patient-reported menstrual and obstetric outcomes following hysteroscopic adhesiolysis for Asherman syndrome.

    Morales B, Movilla P, Wang J, et al.

    F&S reports 2021; (2(1)):118-125 doi:10.1016/j.xfre.2021.01.002.

    PMID: 34223282
  31. 31

    Effectiveness of Hyaluronic Acid Gel and Intrauterine Devices in Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis in Infertile Women.

    Trinh TT, Nguyen KD, Pham HV, et al.

    Journal of minimally invasive gynecology 2022; (29(2)):284-290 doi:10.1016/j.jmig.2021.08.010.

    PMID: 34433103
  32. 32

    Post-hysteroscopy Duration of the Cook Balloon Uterine Stent Effect on the Re-adhesion Formation.

    Qu S, Zhou P

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2021; (31(10)):1163-1167 doi:10.29271/jcpsp.2021.10.1163.

    PMID: 34601835
  33. 33

    Effect of hysteroscopic adhesiolysis on recurrence, menstruation and pregnancy outcomes in patients with different degrees of intrauterine adhesions.

    Wang L, Guo C, Cao H

    American journal of translational research 2022; (14(1)):484-490.

    PMID: 35173868
  34. 34

    Prevalence and risk factors of intrauterine adhesions in women with a septate uterus: a retrospective cohort study.

    Shen M, Duan H, Chang Y, Lin Q

    Reproductive biomedicine online 2022; (44(5)):881-887 doi:10.1016/j.rbmo.2022.02.004.

    PMID: 35361544
  35. 35

    Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome.

    Tavcar J, Movilla P, Carusi DA, et al.

    Journal of minimally invasive gynecology 2023; (30(3)):192-198 doi:10.1016/j.jmig.2022.11.013.

    PMID: 36442752
  36. 36

    Clinical features of the predilection and severer sites of intrauterine adhesions.

    Yu Y, Zou L, Li W, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022; (47(11)):1568-1574 doi:10.11817/j.issn.1672-7347.2022.220248.

    PMID: 36481635
  37. 37

    hUMSCs Restore Uterine Function by Inhibiting Endometrial Fibrosis via Regulation of the MMP-9/TIMP-1 Ratio in CDDP-Induced Injury Rats.

    Tang Y, Si Y, Liu C, et al.

    Stem cells international 2023; (2023()):8014052 doi:10.1155/2023/8014052.

    PMID: 36994440
  38. 38

    The perinatal outcomes of women treated for Asherman syndrome: a propensity score-matched cohort study.

    Mára M, Borčinová M, Lisá Z, et al.

    Human reproduction (Oxford, England) 2023; (38(7)):1297-1304 doi:10.1093/humrep/dead092.

    PMID: 37196339
  39. 39

    Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: a systematic review and meta-analysis.

    Guo J, Shi X, Yu F, et al.

    Human fertility (Cambridge, England) 2023; (26(4)):797-814 doi:10.1080/14647273.2023.2254492.

    PMID: 37778374
  40. 40

    Fertility and anatomical outcomes following hysteroscopic adhesiolysis: An 11-year retrospective cohort study to validate a new classification system for intrauterine adhesions (Urman-Vitale Classification System).

    Urman B, Yakin K, Ertas S, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024; (165(2)):644-654 doi:10.1002/ijgo.15262.

    PMID: 38013507
  41. 41

    A retrospective cohort study to examine factors affecting live birth after hysteroscopic treatment of intrauterine adhesions.

    Zhao Y, Huang X, Huang R, et al.

    Fertility and sterility 2024; (121(5)):873-880 doi:10.1016/j.fertnstert.2024.01.022.

    PMID: 38246404
  42. 42

    Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.

    Zhao J, Li Q, Liao E, et al.

    BMC pregnancy and childbirth 2024; (24(1)):76 doi:10.1186/s12884-024-06254-z.

    PMID: 38262978
  43. 43

    The predictive value of serum IL-17A and IL-6 expression in postoperative recurrence in patients with intrauterine adhesion.

    Cui X, Xiao HC, Pan W

    American journal of reproductive immunology (New York, N.Y. : 1989) 2024; (91(1)):e13808 doi:10.1111/aji.13808.

    PMID: 38282600
  44. 44

    Review of Asherman syndrome and its hysteroscopic treatment outcomes: experience in a low-resource setting.

    Siferih M, Gebre T, Hunduma F, et al.

    BMC women's health 2024; (24(1)):99 doi:10.1186/s12905-024-02944-0.

    PMID: 38326846
  45. 45

    Value of 2D ultrasonography in the diagnosis and evaluation of intrauterine adhesions - a prospective study.

    Huang R, Huang X, Li S, et al.

    Reproductive biomedicine online 2024; (49(2)):103771 doi:10.1016/j.rbmo.2023.103771.

    PMID: 38761561
  46. 46

    Treatment of intrauterine adhesions and subsequent pregnancy outcomes in an in vitro fertilization population.

    Mortimer RM, Lanes A, Srouji SS, et al.

    American journal of obstetrics and gynecology 2024; (231(5)):536.e1-536.e10 doi:10.1016/j.ajog.2024.05.026.

    PMID: 38777163
  47. 47

    Reduced expression of SMAD7 and consequent reduction of autophagy promotes endometrial stromal-myofibroblast transition and fibrosis.

    Yong M, Zhou H, Zeng Y, et al.

    Molecular human reproduction 2024; (30(10)) doi:10.1093/molehr/gaae036.

    PMID: 39412480
  48. 48

    Long-term effects of hysteroscopic adhesiolysis on postoperative pregnancy rates and fertility outcomes in patients with intrauterine adhesions.

    Hu Y, Ma Y, Li W, Qu J

    American journal of translational research 2024; (16(10)):5605-5613 doi:10.62347/GRAK9062.

    PMID: 39544752
  49. 49

    Comparison of hysteroscopic adhesiolysis with electrosurgery instrument or hysteroscopic scissors in the treatment of intrauterine adhesions of infertile or recurrent pregnancy loss women.

    Li Y, Li Y, Wang Y, et al.

    Archives of gynecology and obstetrics 2025; (311(4)):1063-1071 doi:10.1007/s00404-024-07866-8.

    PMID: 39673604
  50. 50

    Extended intrauterine balloon stent use to prevent adhesion reformation after hysteroscopic adhesiolysis: a randomized trial.

    Luo Y, Liu Y, Xiao Y, et al.

    Fertility and sterility 2025; (124(1)):144-152 doi:10.1016/j.fertnstert.2025.01.024.

    PMID: 39884334
  51. 51

    Comparative Analysis of Hysterosalpingography and Diagnostic Hysteroscopy Findings in Infertility Evaluation.

    G M, M S

    Cureus 2025; (17(4)):e81789 doi:10.7759/cureus.81789.

    PMID: 40330349
  52. 52

    Optimal timing of hysteroscopic follow-up to prevent the recurrence of intrauterine adhesions: a retrospective study.

    Dao S, Zhang L, Liu C, et al.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2025; (45(1)):2500970 doi:10.1080/01443615.2025.2500970.

    PMID: 40455065
  53. 53

    Efficacy of high-dose estrogen and progesterone sequential assisted hysteroscopic cold knife separation versus hysteroscopic cold knife separation alone in the treatment of infertility or amenorrhea caused by severe intrauterine adhesion: a retrospective cohort study.

    Wang X, Han J, Song Y

    BMC surgery 2025; (25(1)):246 doi:10.1186/s12893-025-02964-z.

    PMID: 40474175
  54. 54

    "The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.

    Hanstede MMF, Veersema S, Emanuel MH, et al.

    Fertility and sterility 2025; (124(5 Pt 2)):1104-1114 doi:10.1016/j.fertnstert.2025.06.027.

    PMID: 40578664
  55. 55

    XBP1 promotes endometrial fibrosis through cGAS-STING signaling pathway in intrauterine adhesion.

    Wu X, He L, Lin Y, et al.

    Scientific reports 2025; (15(1)):23299 doi:10.1038/s41598-025-06162-y.

    PMID: 40603996
  56. 56

    Single-cell sequencing uncovers disrupted stromal-macrophage communication as a driver of intrauterine adhesion progression.

    Dong E, Zhou Z, Chen T, et al.

    Communications biology 2025; (8(1)):1194 doi:10.1038/s42003-025-08634-3.

    PMID: 40790346
  57. 57

    Determinants of uterine synechiae at hysteroscopy: a case-control study in Kinshasa, Democratic Republic of Congo.

    Nzau-Ngoma E, Lumingu AL, Mindombe PM, et al.

    The Pan African medical journal 2025; (51()):64 doi:10.11604/pamj.2025.51.64.43555.

    PMID: 41064682
  58. 58

    A randomized clinical trial of surgical intervention with or without acupuncture combined with traditional Chinese medicine to treat intrauterine adhesions.

    Wenwen Z, Jiaqi W, Jing S, et al.

    Contemporary clinical trials communications 2025; (48()):101565 doi:10.1016/j.conctc.2025.101565.

    PMID: 41230015
  59. 59

    Diagnostic accuracy of three-dimensional transvaginal ultrasound for intrauterine adhesions: a systematic review and meta-analysis.

    Huang L, Huang Z, Hu B

    Frontiers in medicine 2025; (12()):1690719 doi:10.3389/fmed.2025.1690719.

    PMID: 41341821
  60. 60

    Incidence and Risk Factors for Intrauterine Synechiae in Women With Previous Dilation and Curettage.

    Chen S, Samiezade-Yazd Z, Triplett C, Joshi N

    Obstetrics and gynecology 2026; (147(3)):366-373 doi:10.1097/AOG.0000000000006158.

    PMID: 41505760
  61. 61

    Treatment Outcomes of Individualized PDLLA-Copper Stents Versus Intrauterine Balloons in Moderate-to-Severe Intrauterine Adhesions After Hysteroscopic Adhesiolysis: A Propensity Score-Weighted Analysis.

    Zhao K, Tang S, Zhang F, et al.

    Journal of minimally invasive gynecology 2026; doi:10.1016/j.jmig.2026.01.010.

    PMID: 41521000